Claire Castain

Papers

Total Citations

H-Index

About

Dr. Claire Castain has established herself as a leading pathologist specializing in hepatobiliary neoplasia, with a focused expertise in the molecular underpinnings of rare biliary tract lesions. Her most cited work, the seminal 2014 study "BRAF V600E mutations in bile duct adenomas," represents a landmark contribution to the field. In this investigation, Dr. Castain and her team were the first to identify activating BRAF V600E mutations in bile duct adenomas (BDAs), benign intrahepatic biliary proliferations typically under 5 mm that are often discovered incidentally during surgery or autopsy. This finding was transformative, as it not only provided the first definitive molecular characterization of these enigmatic lesions but also established a critical genetic link between BDAs and their malignant counterparts, such as intrahepatic cholangiocarcinoma. With 26 citations, this work has become a cornerstone reference for pathologists and researchers studying biliary carcinogenesis. Dr. Castain’s research has significantly advanced the understanding of the pathogenesis of rare hepatic tumors, offering new insights into their classification and potential diagnostic markers. Her meticulous approach to elucidating the genetic drivers of these uncommon neoplasms continues to inform both clinical practice and future therapeutic strategies in hepatobiliary oncology.